BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological ...
The gross proceeds from the offering are expected to be approximately $3.13 million, excluding any proceeds that may be received upon exercise of the warrants and before deducting the placement ...
WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company ...
SAN ANTONIO, October 21, 2024--bioAffinity Technologies announces closing of $2.6 million registered direct offering and ...
Jet.AI Inc. (“Jet.AI” or the “Company”) (NASDAQ: JTAI), an innovative private aviation and artificial intelligence company, today announced that it has entered into a securities purchase agreement ...
The company plans to use the proceeds to support exploration at the Lunahuasi project in Argentina and the Los Helados ...
AXCAP VENTURES INC. (CSE:AXCP) (the “Company”) is pleased to announce a non-brokered private placement of up to 50,000,000 special warrants (the “Special Warrants”) at the price of $0.20 per Special ...
AXCAP VENTURES INC. (CSE:AXCP) (the “Company”) is pleased to announce a non-brokered private placement of up to 50,000,000 special warrants (the “Special Warrants”) at the price of $0.20 per Special ...